Скачать или смотреть Thyroid Eye Disease | Assessment, Activity, Severity & Management

In this session, we cover thyroid eye disease (TED) from first principles through to advanced management. The talk focuses on pathophysiology, clinical features, disease activity and severity scoring, and evidence-based management strategies, including medical treatment during the active phase and staged surgical correction once the disease has stabilised.

Key themes include:
⭐ The relationship between thyroid dysfunction and thyroid eye disease, including hyperthyroid, hypothyroid, and euthyroid states.
⭐ Pathophysiology of TED, including antibody-mediated orbital inflammation and subsequent fibrotic restrictive myopathy.
⭐ Core clinical features affecting soft tissues, lids, globe position, extraocular muscles, and the optic nerve.
⭐ Recognition and assessment of dysthyroid optic neuropathy as a sight-threatening complication.
⭐ Use of Rundle’s curve to understand disease activity and timing of interventions.
⭐ Clinical Activity Score (CAS) and how it differs from disease severity.
⭐ Severity-based management following EUGOGO principles, from mild to sight-threatening disease.

Take-home messages:
🌟 Thyroid eye disease can occur in any thyroid state and requires ophthalmic assessment independent of thyroid control.
🌟 Disease activity and disease severity are separate concepts and guide different management decisions.
🌟 Optic neuropathy and severe corneal exposure require urgent treatment.
🌟 Medical therapy is indicated during the active phase; surgery is reserved for stable disease and performed in a staged sequence.

🔗 Join the WhatsApp group for live session updates:
https://chat.whatsapp.com/KoTWgwUWL7D...
📝 Leave feedback for the teaching:
https://forms.gle/DDBfq5cTLSBaUJnL6